Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Ekso Bionics Holdings (EKSO) over the last 13 years, with Q3 2025 value amounting to 34.02%.

  • Ekso Bionics Holdings' EBITDA Margin rose 289300.0% to 34.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 75.57%, marking a year-over-year decrease of 85400.0%. This contributed to the annual value of 58.74% for FY2024, which is 266300.0% up from last year.
  • According to the latest figures from Q3 2025, Ekso Bionics Holdings' EBITDA Margin is 34.02%, which was up 289300.0% from 185.51% recorded in Q2 2025.
  • In the past 5 years, Ekso Bionics Holdings' EBITDA Margin registered a high of 34.02% during Q3 2025, and its lowest value of 185.51% during Q2 2025.
  • In the last 5 years, Ekso Bionics Holdings' EBITDA Margin had a median value of 78.21% in 2023 and averaged 90.84%.
  • As far as peak fluctuations go, Ekso Bionics Holdings' EBITDA Margin soared by 4650400bps in 2021, and later crashed by -1385600bps in 2025.
  • Over the past 5 years, Ekso Bionics Holdings' EBITDA Margin (Quarter) stood at 64.62% in 2021, then crashed by -79bps to 115.49% in 2022, then soared by 32bps to 78.21% in 2023, then soared by 38bps to 48.49% in 2024, then rose by 30bps to 34.02% in 2025.
  • Its last three reported values are 34.02% in Q3 2025, 185.51% for Q2 2025, and 101.45% during Q1 2025.